What is a stock summary page? Click here for an overview.
Business Description
Annovis Bio Inc
NAICS : 325411
SIC : 2833
ISIN : US03615A1088
Share Class Description:
FRA:07X: Ordinary SharesDescription
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.67 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -4.7 | |||||
| 3-Year EPS without NRI Growth Rate | -11.1 | |||||
| 3-Year FCF Growth Rate | -14.4 | |||||
| 3-Year Book Growth Rate | -50.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23 | |||||
| 9-Day RSI | 29.48 | |||||
| 14-Day RSI | 29.35 | |||||
| 3-1 Month Momentum % | -65.8 | |||||
| 6-1 Month Momentum % | -76.19 | |||||
| 12-1 Month Momentum % | -84.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.59 | |||||
| Quick Ratio | 3.59 | |||||
| Cash Ratio | 2.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.4 | |||||
| Shareholder Yield % | -60.26 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -3496.87 | |||||
| ROA % | -239.41 | |||||
| ROIC % | -11193.29 | |||||
| ROC (Joel Greenblatt) % | -11193.29 | |||||
| ROCE % | -462.24 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.42 | |||||
| Price-to-Tangible-Book | 2.39 | |||||
| EV-to-EBIT | -0.69 | |||||
| EV-to-Forward-EBIT | -2.23 | |||||
| EV-to-EBITDA | -0.69 | |||||
| EV-to-Forward-EBITDA | -0.46 | |||||
| EV-to-FCF | -0.84 | |||||
| Price-to-Net-Current-Asset-Value | 2.39 | |||||
| Price-to-Net-Cash | 3.79 | |||||
| Earnings Yield (Greenblatt) % | -144.93 | |||||
| FCF Yield % | -70.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Annovis Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.786 | ||
| Beta | 2.52 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.17 | ||
| Volatility % | 118.57 | ||
| 14-Day RSI | 29.35 | ||
| 14-Day ATR (€) | 0.103197 | ||
| 20-Day SMA (€) | 1.5897 | ||
| 12-1 Month Momentum % | -84.42 | ||
| 52-Week Range (€) | 1.364 - 16.2 | ||
| Shares Outstanding (Mil) | 19.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Annovis Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Annovis Bio Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Annovis Bio Inc Frequently Asked Questions
What is Annovis Bio Inc(FRA:07X)'s stock price today?
The current price of FRA:07X is €1.36. The 52 week high of FRA:07X is €16.20 and 52 week low is €1.36.
When is next earnings date of Annovis Bio Inc(FRA:07X)?
The next earnings date of Annovis Bio Inc(FRA:07X) is 2025-05-13 Est..
Does Annovis Bio Inc(FRA:07X) pay dividends? If so, how much?
Annovis Bio Inc(FRA:07X) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers